Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lupus Nephritis
100%
Systemic Lupus Erythematosus
58%
Lupus
28%
Accelerating Medicines Partnership
16%
American College of Rheumatology
15%
Single-cell Transcriptomics
15%
Fibrosis
14%
Kidney
13%
Inflammation
11%
25-hydroxyvitamin D (25OHD)
11%
Kidney Biopsy
11%
Proteinuria
11%
Urine Proteome
11%
Raynaud's Phenomenon
11%
Autoantibodies
10%
25(OH)D Level
10%
Scleroderma
9%
Tubular Cells
9%
Immune Landscape
9%
Immunology
9%
Keratinocytes
9%
Epitope
9%
Pericarditis
9%
Meta-analysis
9%
Histopathological Features
9%
25-hydroxyvitamin D Levels
9%
COVID-19
9%
Historical Perspective
9%
End-stage Kidney Disease
9%
Treatment Response
9%
Prednisone
8%
Urine Protein-to-creatinine Ratio
7%
Autoimmune Disease
7%
Clinically Indicated
7%
Systemic Sclerosis
7%
Interferon-α (IFN-α)
7%
Intrarenal
6%
Cardiovascular Events
6%
Blood Levels
6%
Immunomodulatory Drugs (IMiDs)
6%
Healthy Controls
6%
Hydroxychloroquine
6%
Estimated Glomerular Filtration Rate
6%
Standard-of-care Therapy
6%
Granzyme B
6%
Renal Biopsy
6%
Complete Response
6%
Rheumatoid Arthritis
5%
Secondary Raynaud's Phenomenon
5%
Autoimmune Connective Tissue Diseases
5%
Immunology and Microbiology
Lupus Erythematosus
77%
Nephritis
64%
Systemic Lupus Erythematosus
61%
Proteomics
22%
Scleroderma
16%
Lung
16%
Systemic Scleroderma
16%
T Cell
12%
Autoantibodies
10%
T-Helper Cell
10%
Raynaud Phenomenon
9%
Pericarditis
9%
interferon
9%
Monocyte
9%
Autoimmune Disease
8%
Inflammation
8%
Prednisone
8%
Infection
8%
Infectious Disease
8%
Myeloid
7%
Immunosuppressant
7%
COVID-19
7%
Transcriptomics
6%
Belimumab
6%
Blood Level
6%
Autoimmunity
6%
Cell Population
6%
Neutrophil
6%
Immune Response
5%
Connective Tissue
5%
B Cell
5%
Interleukin 16
5%
Hydroxychloroquine
5%
Glomerulus Filtration
5%
Inflammatory Arthritis
5%
Immunocompetent Cell
5%
Ribonucleic Acid
5%
Medicine and Dentistry
Lupus Nephritis
78%
Systemic Lupus Erythematosus
41%
Lupus Erythematosus
26%
Rheumatology
25%
Fibrosis
15%
Raynaud Phenomenon
14%
Diseases
14%
Renal Biopsy
13%
Creatinine
12%
Proteinuria
11%
Biopsy Technique
11%
Systemic Scleroderma
11%
Treatment Response
11%
Proteomics
11%
Transcriptomics
10%
Biological Marker
10%
Immunology
9%
End Stage Renal Disease
9%
Keratinocyte
9%
Interstitial Lung Disease
8%
Kidney Injury
8%
Systematic Review
7%
Prednisone
7%
Inflammation
7%
Scleroderma
7%
Glomerular Filtration Rate
6%
Flow Cytometry
6%
Interferon Type I
6%
Immunocompetent Cell
5%
Histopathology
5%
Belimumab
5%
Quality of Life
5%
T-Helper Cell
5%
